Editorial: the haemolytic anaemias--a brief review of recent advances.
D000740:Anemia / Q000628:therapy; D000743:Anemia, Hemolytic; D000744:Anemia, Hemolytic, Autoimmune / Q000276:immunology; D000745:Anemia, Hemolytic, Congenital / Q000201:enzymology; D001323:Autoantibodies; D002462:Cell Membrane; D004899:Erythroblastosis, Fetal / Q000276:immunology; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D005826:Genetics, Medical; D005955:Glucosephosphate Dehydrogenase Deficiency; D005978:Glutathione / Q000378:metabolism; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D006455:Hemoglobins, Abnormal; D006457:Hemoglobinuria, Paroxysmal / Q000276:immunology; D007108:Immune Tolerance; D008750:Methyldopa / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000209:etiology; D011247:Pregnancy; D011770:Pyruvate Kinase; D013103:Spherocytosis, Hereditary / Q000209:etiology; D013156:Splenectomy
D001323:Autoantibodies; D006455:Hemoglobins, Abnormal; D008750:Methyldopa; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D011770:Pyruvate Kinase; D005978:Glutathione